STOCK OPTION AGREEMENTStock Option Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT made and entered into effective as of _______, 20__, by and between OncoCyte Corporation., a California corporation (the “Company”), and __________, an employee (the “Employee”) of the Company.
STOCK SUBSCRIPTION AGREEMENT ONCOCYTE CORPORATION READ THIS AGREEMENT CAREFULLY BEFORE YOU INVESTStock Subscription Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
This Agreement is entered into by Bernard Karfunkel (“Subscriber”) and OncoCyte Corporation, a California corporation (the “Company”).
First Amendment to the Sponsored Research AgreementSponsored Research Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • Pennsylvania
This FIRST AMENDMENT TO THE SPONSORED RESEARCH AGREEMENT (the "First Amendment") is made as of the date of the last signature below (the "First Amendment Effective Date"), by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a Pennsylvania nonprofit corporation located at 3601 Spruce Street, Philadelphia, PA 19104 ("Wistar"), and ONCOCYTE CORPORATION, a corporation organized under the laws of California, with a principal place of business located at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("Sponsor"). Wistar and Sponsor shall be referred to herein individually as a "Party" and collectively as the "Parties."
SHARED FACILITIES AND SERVICES AGREEMENTShared Facilities and Services Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances
This Agreement is made as of October 8, 2009 (the Effective Date) by and between BioTime, Inc. (BioTime) and OncoCyte Corporation (OncoCyte).
EMPLOYMENT AGREEMENTEmployment Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT is made April 1, 2011, by and between OncoCyte Corporation, a California corporation (the "Company"), BioTime, Inc., a California corporation (“BioTime”), and Karen Chapman, Ph.D. ("Employee").
INCENTIVE STOCK OPTION AGREEMENT OncoCyte CorporationIncentive Stock Option Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT made and entered into as of ______________, 20__ by and between OncoCyte Corporation, a California corporation (the "Company"), and _____________, an employee (the "Employee") of the Company or of a subsidiary of the Company (hereinafter included within the term "Company") within the meaning of Section 424(f) of the Internal Revenue Code of 1986, as amended (the "Code"),
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
This Registration Rights Agreement (“Agreement”) is entered into as of October 15, 2009 by and between OncoCyte Corporation, a California corporation (the “Company”) and the undersigned.
EMPLOYMENT AGREEMENTEmployment Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT is made June 15, 2015, by and between OncoCyte Corporation, a California corporation (the “Company”), and William Annett (“Executive”).
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • Pennsylvania
This SPONSORED RESEARCH AGREEMENT (the "Agreement") is made as of the 13th day of September, 2013 (the "Effective Date") by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a Pennsylvania nonprofit corporation located at 3601 Spruce Street, Philadelphia, PA 19104 ("Wistar"), and ONCOCYTE CORPORATION, a corporation organized under the laws of California, with a principal place of business located at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("Sponsor").
AMENDEMENT OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances
This Amendment of Registration Rights Agreement (“Agreement”) is entered into as of August 23, 2011 by and between OncoCyte Corporation, a California corporation (the “Company”), and the undersigned Holders.
AGREEMENTInvestment Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • New York
This AGREEMENT (this “Agreement”) is made as of June 26, 2015 (the “Effective Date”) by and among George Karfunkel, Bernard Karfunkel (together with George Karfunkel, the “Investors”) and OncoCyte Corporation, a California corporation (“OncoCyte” and together with the Investors, individually each a “Party” and collectively, the “Parties”).
SECOND AMENDEMENT OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances
This Second Amendment of Registration Rights Agreement (“Agreement”) is entered into as of May 8, 2015 by and between OncoCyte Corporation, a California corporation (the “Company”), and the undersigned Holders.
EMPLOYMENT AGREEMENTEmployment Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS EMPLOYMENT AGREEMENT (“Agreement”) is made as of August 01, 2015 by and between OncoCyte Corporation (“OncoCyte”), a California corporation, and Kristine Mechem ("Executive").
Second Amendment to the Sponsored Research AgreementSponsored Research Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances
This SECOND AMENDMENT TO THE SPONSORED RESEARCH AGREEMENT (the "Second Amendment") is made as of the date of the last signature below (the "Second Amendment Effective Date"), by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a Pennsylvania nonprofit corporation located at 3601 Spruce Street, Philadelphia, PA 19104 ("Wistar"), and ONCOCYTE CORPORATION, a corporation organized under the laws of California, with a principal place of business located at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("Sponsor"). Wistar and Sponsor shall be referred to herein individually as a "Party" and collectively as the "Parties."
